We live in an age when science and technology touch nearly every aspect of our lives. Yet scientific findings on climate change, vaccines and evolution are increasingly under attack. Why people doubt science.
Guest Host: Steve Roberts
A new study suggests antidepressants may be no more effective than placebo in all but severe cases of depression. A look at how drug effectiveness is measured and weighed against safety concerns in and beyond the drug approval process.
- Dr. William Potter serves on the FDA's Psychopharmacologic Drugs Advisory Committee, vice president for translational neuroscience at Merck Research Laboratories; board-certified psychiatrist
- Dr. Jerry Avorn Professor of Medicine at Harvard Medical School; Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital; author "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs"
- Blair Johnson professor of psychology, University of Connecticut; coauthor on new antidepressant study
- Gardiner Harris science reporter for "The New York Times"
Most Recent Shows
On Tuesday, Israeli Prime Minister Benjamin Netanyahu delivered a much-debated speech to Congress. We look at reaction to the speech here and abroad and efforts to reduce U.S.-Israeli tensions over a possible nuclear agreement with Iran.
President Barack Obama has proposed opening up new areas for offshore drilling, including in the Atlantic. For this month's Environmental Outlook, Diane and her guests discuss the prospects for finding oil and gas offshore, and the environmental and safety concerns.
The Supreme Court takes up a major challenge to the Affordable Care Act this week. The ruling could make health insurance unaffordable for millions of Americans. We take a look at King v. Burwell and the future of the ACA.